𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biliary and urinary excretions of immunoreactive human epidermal growth factor after intravenous administration in rats

✍ Scribed by Murakami, Teruo; Kishimoto, Miki; Higashi, Yutaka; Amagase, Harunobu; Hayashi, Tomonori; Fuwa, Toru; Yata, Noboru

Book ID
122911418
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
528 KB
Volume
49
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Urinary cyclophosphamide excretion in ra
Urinary cyclophosphamide excretion in rats after intratracheal, dermal, oral and intravenous administration of cyclophosphamide
✍ P. J. M. Sessink; P. H. H. van den Broek; R. P. Bos πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 344 KB πŸ‘ 1 views

## Abstract The urinary excretion of unmetabolized cyclophosphamide was studied in rats after intratracheal, dermal, oral and intravenous administration. Rats were given two doses of 1 mg kg^βˆ’1^ cyclophosphamide 48 h apart and urine was collected for 96 h after the first treatment. With the help o

Biliary excretion of7Be and its distribu
Biliary excretion of7Be and its distribution after intravenous administration of7BeCl2in rats
✍ M. Cikrt; V. Bencko πŸ“‚ Article πŸ“… 1975 πŸ› Springer-Verlag 🌐 English βš– 431 KB

Wistar female rats were given two i.v. doses of 7BeCl2 (dose A = 0.025 mg Be2+/kg b.w.; dose B = 0.25 mg Be2+/kg b.w.). The rats were decapitated at 5, 24, and 48 hrs after administration. The kinetics of 7Be bile excretion during the 5 hrs after administration, as well as 7Be retention in selected

Plasma pharmacokinetics and urinary and
Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration
✍ A. Kiriyama; K. Fujita; S. Takemura; H. Kuramoto; Y. Kiso; K. Takada πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 555 KB

The pharmacokinetic (PK) characteristics of KNI-272, a potent and selective HIV-1 protease inhibitor, were evaluated in rats after intravenous (IV) administration. The effect of dose on KNI-272 plasma kinetics, and the urinary and biliary elimination kinetics of KNI-272, were examined. After IV admi